Filing Details
- Accession Number:
- 0001181431-12-024006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-16 12:57:33
- Reporting Period:
- 2012-04-12
- Filing Date:
- 2012-04-16
- Accepted Time:
- 2012-04-16 11:57:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1400431 | Patheon Inc | PTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1517835 | James Mark Kontny | 4721 Emperor Blvd Suite 200 Durham NC 27703 | President Global Pharmaceutica | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Voting Shares | Acquisiton | 2012-04-12 | 13,120 | $2.26 | 13,120 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.22 to $2.31, inclusive. The reporting person undertakes to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote (1). The amounts reported in column 4 and this footnote (1) were converted from Canadian dollars into U.S. dollars based on the April 12, 2012 closing exchange rate of 0.9946 Canadian dollars per U.S. dollar as quoted by Reuters.
Billionaire Hedge Funds
